期刊文献+

拉科酰胺原料药中有关物质的合成

Synthesis of related substances of lacosamide
原文传递
导出
摘要 目的研究拉科酰胺原料药中有关物质的来源及合成方法,为产品质量控制提供依据和杂质对照品。方法在参考拉科酰胺原料药相关合成方法的基础上,以Boc-D-丝氨酸为原料,经多步反应分别制得拉科酰胺的6种有关物质:(R)-2-氨基-N-苄基-3-羟基丙酰胺(A)、(R)-2-乙酰胺基-N-苄基-3-羟基丙酰胺(B)、(2R)-2-(乙酰胺基)-3-(乙酰氧基)-N-(苯甲基)丙酰胺(C)、N-[(1R)-1-(甲氧基甲基)-2-氧代-2-[(苯基甲基)氨基]乙基]-2-甲基丙酯(D)、(R)-N-苄基-2-(3-苄基脲基)-3-甲氧基丙酰胺(E)、(R)-N-苄基-3-甲氧基-2-(N-甲基乙酰氨基)丙酰胺(F)。结果与结论合成的6种拉科酰胺有关物质的结构经1H-NMR、13C-NMR、HR-MS谱确证,可作为拉科酰胺原料药的杂质对照品,其中有关物质E和F为新化合物。 To improve the quality control of lacosamide,six related substances were synthesized.(R)-2-Amino-N-benzyl-3-hydroxypropanamide(A),(R)-2-acetamido-N-benzyl-3-hydroxypropanamide(B)and(2R)-2-(acetamido)-3-(acetyloxy)-N-(phenylmethyl)propanamide(C)were synthesized based on the use of Boc-D-serine as raw material.N-[(1R)-1-(methoxymethyl)-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-methylpropyl ester(D),(R)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide(E)and(R)-N-benzyl-3-methoxy-2-(N-methylacetamido)propanamide(F)were synthesized from(R)-2-amino-N-benzyl-3-methoxyproplonamide.In addition,impurity E and impurity F were new compounds,the structures of them were characterized by 1H-NMR,13C-NMR and HR-MS.The purities of impurity A,B,C,D,E,and F was 95.3%,99.6%,99.9%,98.4%,99.7%,and 99.7%,respectively by HPLC analysis which can be used as reference substances for the lacosamide.
作者 陈梦迪 杨安江 张晓庆 张福利 赵春杰 CHEN Meng-di;YANG An-jiang;ZHANG Xiao-qing;ZHANG Fu-li;ZHAO Chun-jie(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China;Shanghai Institute of Pharmaceutical Industry,China State Institute of Pharmacetical Industry,Shanghai 201203,China)
出处 《中国药物化学杂志》 CAS CSCD 北大核心 2019年第3期219-223,共5页 Chinese Journal of Medicinal Chemistry
关键词 拉科酰胺 有关物质 合成 抗癫痫药 lacosamide related substance synthesis antiepileptic drug
  • 相关文献

参考文献4

二级参考文献20

  • 1CHOI D, STABLES, J P, KHON H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropi- on-amide derivatives [ J ]. J Med Chem, 1996,39 ( 9 ) : 1907-1916.
  • 2Research Corporation Tech , KHON H , ANDURKAR S V. Anticonvulsant enantiomeric amino acid derivatives: US ,6048899 A[ P]. 2000 - 04 - 11
  • 3Schwarz Pharma A G,RIEDNER J. Improved synthesis scheme for lacosamide: EP, 1642889 A1 [ P]. 2006 - 04 - 05.
  • 4Errington AC, Coyne L, Stohr T, et al. Seeking a mechanism of action for the novel anticonvulsant lacosamide [J]. Neuropharmacology, 2006, 50 (8) : 1016-1029.
  • 5Beyreuther BK, Freitag J, Heers C, et al. Lacosamide: a review of preclinical properties [J]. CNS Drug Rev, 2007, 13(1): 21-42.
  • 6Choi D, Stables JP, Kohn H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives [J]. JMed Chem, 1996, 39 (9) : 1907-1916.
  • 7Riedner J. Improved synthesis scheme for lacosamide: EP, 1642889 [P]. 2006-04-05. (CA 2006, 144:331695).
  • 8Morieux P, Stables JP, Kohn H. Synthesis and anticonvulsant activities of N-benzyl (2R) -2-acetamido-3-oxysubstituted propionamide derivatives [J]. Bioorg Med Chem, 2008, 16 (19) : 8968-8975.
  • 9Kohn H, Andurkar SV. Anticonvulsant enantiomeric amino acid derivatives: US, 6048899 [P]. 2000-04-01. (CA 2000, 132: 78846).
  • 10Garner P, Park JM. The synthesis and configurational stability of differentially protected 13-hydroxy-α-amino aldehydes [J]. J Org Chem, 1987, 52 (12) : 2361-2364.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部